Showing results (71-80 of 186) with videos related to

Sort By:
Pageof 19
Cancer|July 7, 2011
Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced diseaseAlessandra Tedeschi, Giulia Benevolo, Marzia Varettoni, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2025
Impact of edoxaban-related adverse events in patients with cancer experiencing venous thromboembolism during antineoplastic therapy: Results of the phase IV EDOI study (GOIRC-05-2018)Giuseppe Maglietta, Angela Damato, Silvia Finotto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneTina Marie Green, Ken H Young, Carlo Visco, et al.
Haematologica|April 11, 2020
Genetic lesions in MYC and STAT3 drive oncogenic transcription factor overexpression in plasmablastic lymphomaJulia Garcia-Reyero, Nerea Martinez Magunacelaya, Sonia Gonzalez de Villambrosia, et al.
Bioorganic & Medicinal Chemistry|July 2, 2014
Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitorsElena Casale, Nadia Amboldi, Maria Gabriella Brasca, et al.
European Journal of Haematology|August 2, 2006
Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosisCarlo Visco, Gianpaolo Nadali, Theodoros P Vassilakopoulos, et al.
Blood|October 2, 2019
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter studyCarlo Visco, Francesco Rodeghiero, Alessandra Romano, et al.
Leukemia & Lymphoma|April 29, 2020
Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphomaMichele Merli, Irene Defrancesco, Carlo Visco, et al.
Cancers|February 24, 2024
Kaposi's Sarcoma: Evaluation of Clinical Features, Treatment Outcomes, and Prognosis in a Single-Center Retrospective Case SeriesIrene Russo, Dario Marino, Claudia Cozzolino, et al.
American Journal of Hematology|July 18, 2013
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practiceFrancesco Zaja, Michael Mian, Stefano Volpetti, et al.
Pageof 19